Document:

EXECUTION
VERSION

 

All
amounts (including all principal, interest, and other payments) payable by Maker under this Note are and shall be subordinate
and junior in right of payment to the prior payment in full in cash of the indebtedness of Maker in favor of Silicon Valley Bank
under that certain Loan and security Agreement dated as of November 13, 2018, as may be amended from time to time, and the termination
of all related commitments, TO THE EXTENT PROVIDED IN SECTION 7 hereof.

 

this
note HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (“SECURITIES ACT”), AS AMENDED, OR ANY STATE SECURITIES
LAW. THIS NOTE MAY NOT BE SOLD, ASSIGNED, or TRANSFERRED UNLESS THE SAME IS REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES
LAWS OR UNLESS AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE AND MAKER HAS RECEIVED EVIDENCE OF SUCH EXEMPTION (Other than
an opinion of COUNsel) REASONABLY SATISFACTORY TO MAKER.

 

SUBORDINATED
SELLER NOTE

 

	$7,692,300	July
    15, 2019

 

FOR
VALUE RECEIVED, Interpace BioPharma, Inc., a Delaware corporation (the “Maker”), for value received, hereby
promises to pay to Cancer Genetics, Inc., a Delaware corporation (“Payee”), the principal amount of SEVEN MILLION
SIX HUNDRED NINETY-TWO THOUSAND THREE HUNDRED DOLLARS ($7,692,300), together with all accrued and unpaid interest thereon (the
“Principal Amount”), in accordance with the provisions of this Promissory Note (this “Note”)
on the earlier of (a) July 15, 2022, (b) approval by the shareholders of Interpace Diagnostics Group, Inc., Maker’s parent
(“Interpace”), of an investment after the date hereof by Ampersand Capital Partners or any of its Affiliates
or related parties (collectively, “Ampersand”) into Interpace or Maker and the subsequent consummation of the
Ampersand Second Closing and (c) prepayment under Section 4 hereof (such earlier date, the “Maturity Date”).
In addition, Maker shall pay interest on the unpaid Principal Amount in accordance with Section 1 hereof.

 

This
Note is being delivered pursuant to Section 2.4 of that certain Secured Creditor Asset Purchase Agreement, dated as of the date
hereof (as amended, supplemented or otherwise modified from time to time, the “Purchase Agreement”), among
Payee, the other parties named therein, and Maker. Capitalized terms used and not otherwise defined herein shall have the respective
meanings ascribed to such terms in the Purchase Agreement.

 

1.
Interest.

 

1.1
Interest Rate. Interest on the outstanding Principal Amount, as increased or decreased pursuant to Section 1.5 hereof,
shall accrue from the date hereof until repayment in full of the Principal Amount at an aggregate per annum rate equal to six
percent (6.0%) per annum (the “Interest Rate”). Interest will be computed on the basis of a 360-day year, and
in each case, for the actual number of days elapsed. Commencing on September 30, 2019, and continuing on the last day of each
consecutive calendar quarter thereafter, Maker shall make quarterly payments of accrued but unpaid interest, in arrears, to Payee,
until the Maturity Date. All accrued and unpaid interest shall be payable in full on the Maturity Date if not otherwise paid prior
to such date.

 

    	 

     

    

 

1.2
Savings Clause. In no contingency or event shall the Interest Rate charged pursuant to the terms of this Note exceed the
highest rate permissible under any law which a court of competent jurisdiction shall, in a final determination, deem applicable
hereto. In the event that such a court determines that Payee has received interest hereunder in excess of the highest applicable
rate, the amount of such excess interest shall be applied against the Principal Amount then outstanding to the extent permitted
by applicable Law, and any excess interest remaining after such application shall be refunded promptly to Maker.

 

1.3
Holdback on Maturity Date. In order to secure Payee’s obligation to satisfy potential indemnification obligations
under the Purchase Agreement, in the event the Maturity Date occurs prior to the date that is six (6) months from the date hereof,
Maker shall be entitled to deposit on the Maturity Date in a separate account with Maker or its Affiliates an amount equal to
(i) Seven Hundred Thirty Five Thousand Dollars ($735,000), less (ii) the sum of any payments previously satisfied via set-off
against this Note under and in accordance with the terms of Article 7 of the Purchase Agreement (the “Holdback”)
and to pay Payee all amounts due hereunder reduced by the Holdback and, to the extent applicable, the AR Holdback. Thereafter
Maker shall be entitled to set-off against the sums in the Holdback account any amounts due pursuant to the terms of Article 7
of the Purchase Agreement. On the date that is six (6) months after the date hereof, any amounts then remaining in the Holdback
account shall be promptly paid and released to Payee, subject to continued withholding of Maker’s good faith estimate of
amounts due in respect of any then pending indemnification claims, on the terms set forth in Section 7.4 of the Purchase Agreement.
Upon resolution of such pending indemnification claims, any balance remaining in the Holdback account shall be promptly paid and
released to Payee. Amounts subject to the Holdback shall continue to accrue interest until paid.

 

1.4
AR Holdback on Maturity Date. In the event the Maturity Date occurs prior to the date on which the Old Accounts Receivable
Unpaid Amount as of December 31, 2019 has been determined pursuant to Section 2.10(a) of the Purchase Agreement, Maker shall be
entitled to deposit on the Maturity Date in a separate account with Maker or its Affiliates an amount equal to the estimated AR
Holdback as of September 30, 2019 calculated in accordance with Section 2.10(b) of the Purchase Agreement and to pay Payee all
amounts due hereunder reduced by the AR Holdback and, to the extent applicable, the Holdback. After the final Old Accounts Receivable
Unpaid Amount as of December 31, 2019 is determined pursuant to Section 2.10(a) of the Purchase Agreement, any amounts then remaining
in the AR Holdback account shall thereafter be released to Payee or Maker, as applicable, as promptly as practicable after, and
consistent with, the final resolution of the Old Accounts Receivable Unpaid Amount in accordance with Section 2.10 of the Purchase
Agreement, in immediately available funds and deposited in such account designated by Payee or Maker, as applicable, in writing.
Amounts subject to the AR Holdback shall continue to accrue interest until paid.

 

1.5
Set-off, Reductions, Increases.

 

(a)
The Principal Amount of this Note plus any accrued and unpaid interest thereon shall be (i) reduced or increased by the amount
of any post-closing adjustment pursuant to Section 2.9 of the Purchase Agreement, (ii) decreased by the amount of any indemnification
amounts payable by Payee pursuant to Article 7 of the Purchase Agreement, and (iii) if the Maturity Date has not occurred prior
to the Transition Services Payroll End Date, decreased by an amount equal to the Old Accounts Receivable Unpaid Amount pursuant
to Section 2.10(a) of the Purchase Agreement, in each case of the foregoing clauses (i), (ii) and (iii) subject
to the procedures set forth in the Purchase Agreement. All such amounts shall be applied first to unpaid interest, then to unpaid
principal, and finally to unpaid fees, costs and expenses.

 

    	-2-

     

    

 

(b)
Prior to the Maturity Date, the Holdback plus any accrued and unpaid interest thereon shall be reduced by the amount of any indemnification
amounts payable by Payee pursuant to Article 7 of the Purchase Agreement, subject to the procedures set forth therein. All such
amounts shall be applied first to unpaid interest, then to unpaid principal, and finally to unpaid fees, costs and expenses.

 

2.
Time of Payment. If any payment on this Note shall become due on a Saturday, Sunday or legal holiday under the Laws of
the State of Delaware, such payment shall be made on the next succeeding day that is not a Saturday, Sunday or such legal holiday
(a “Business Day”) and, in the case of any payment of the Principal Amount, such extension of time shall in
such case be included in computing interest in connection with such payment.

 

3.
Default.

 

3.1
Event of Default. The occurrence of any one or more of the following events with respect to Maker shall constitute an event
of default hereunder (each, an “Event of Default”):

 

(a)
If Maker shall fail to pay (i) the Principal Amount on the Maturity Date, or (ii) any cash interest payment on the due date thereof
and such failure continues for ten (10) days after Payee notifies Maker thereof in writing.

 

(b)
If, pursuant to or within the meaning of the United States Bankruptcy Code or any other federal or state Law relating to insolvency
or relief of debtors (a “Bankruptcy Law”), Maker shall (i) commence a voluntary case or proceeding, (ii) consent
to the entry of an order for relief against it in an involuntary case (or an order for relief shall be entered in such case),
(iii) consent to the appointment of a trustee, receiver, assignee, liquidator or similar official or (iv) make an assignment for
the benefit of its creditors.

 

(c)
If a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against Maker in
an involuntary case, (ii) appoints a trustee, receiver, assignee, liquidator or similar official for Maker or substantially all
of Maker’s properties, or (iii) orders the liquidation of Maker, and in each case the order or decree is not dismissed within
30 days.

 

(d)
If a default or event of default occurs under that certain Loan and Security Agreement, dated as of November 13, 2018, by and
between Maker and Silicon Valley Bank, as it may be amended, restated, replaced or otherwise modified from time to time.

 

3.2
Remedies. Upon the occurrence and during the continuance of an Event of Default hereunder, (a) if such Event of Default
is specified in Section 3.1(b) or (c) above, this Note and the Principal Amount and accrued interest hereunder together
with any additional amounts payable hereunder shall be immediately due and payable without demand or notice of any kind, (b) if
such Event of Default is specified in Section 3.1(a) or (d) above, Payee may, at its option, by written notice to
Maker, declare this Note and the entire Principal Amount and accrued interest hereunder together with any additional amounts payable
hereunder, immediately due and payable, and (c) Payee may, at its option, exercise any and all rights and remedies available to
it under applicable Law, including the right to collect from Maker all sums due under this Note.

 

    	-3-

     

    

 

4.
Prepayments. Maker may, without premium or penalty, at any time and from time to time, prepay all or any portion of this
Note, but in any case subject to Section 7 below.

 

5.
Method of Payment. All amounts (including all principal, interest, and other payments) payable by Maker under this Note
shall be made by check to Payee at such place in the United States of America as Payee shall designate to Maker in writing; or
by wire transfer of immediately available funds to an account designated by Payee in writing.

 

6.
Waivers. Maker hereby expressly waives all defenses of a maker of a note that may be available to it including, without
limitation, presentment for payment, demand, notice of dishonor, protest and notice of protest.

 

7.
Subordination.

 

7.1
All amounts (including principal, interest and other payments) payable by Maker under this Note are and shall be subordinate and
junior in right of payment to the prior payment in full of the indebtedness of Maker in favor of Silicon Valley Bank under that
certain Loan and Security Agreement, dated as of November 13, 2018, as it may be amended from time to time; except that (i) payments
by Maker may be made hereunder when due and are permitted and obligated unless and until such time as Silicon Valley Bank has
delivered notice to Payee that an Event of Default has occurred and is continuing under its Loan and Security Agreement, and it
has accelerated payment of the obligations of Maker thereunder, in which case payments hereunder will be prohibited for so long
as such Event of Default is outstanding and has not been waived or cured, but (ii) notwithstanding the foregoing, all principal,
interest and other payments due hereunder shall be paid immediately within one Business Day of the Maturity Date, if the Maturity
Date occurs because the shareholders of Interpace have approved an investment by Ampersand after the date hereof and such investment
by Ampersand is consummated.

 

7.2
Maker represents and warrants to Payee that Ampersand is legally obligated to make an investment in Interpace after the date hereof
subject only to approval by the Ampersand shareholders (or their equivalent) and customary closing conditions, and it knows of
no reason why all such closing conditions to such investment by Ampersand, as provided for in an agreement dated as of the date
hereof, will not be satisfied, except no representation is made with respect to the vote of its shareholders (other than that
the Board of Directors of Interpace will recommend that its shareholders approve such investment). Maker covenants and agrees,
and it has obtained the agreement of Interpace for the benefit of Payee, (i) to seek shareholder approval of the Ampersand investment
as promptly as practical, and in any event prior to September 30, 2019, and (ii) to close the Ampersand investment as promptly
as practical within no more than five (5) Business Days after receiving shareholder approval (or to pay all principal, interest
and other amounts due on this Note within five (5) Business Days after receiving shareholder approval notwithstanding anything
set forth in Section 7.1 above).

 

    	-4-

     

    

 

8.
Payee Representations and Warranties. Payee hereby represents and warrants to Maker as follows, which representations and
warranties shall survive the date hereof for so long as this Note remains outstanding:

 

8.1
Payee is acquiring this Note solely for its own account for investment purposes and not with a view to, or for offer or sale in
connection with, any distribution thereof;

 

8.2
Payee acknowledges that this Note is not registered under the Securities Act, or any state securities Laws, and that this Note
may not be transferred or sold except pursuant to the registration provisions of the Securities Act or pursuant to an applicable
exemption therefrom and subject to state securities Laws and regulations, as applicable;

 

8.3
Payee is an “accredited investor” as such term is defined in Rule 501(a) promulgated under the Securities Act;

 

8.4
Payee confirms that Maker has made available (or caused to be made available) to Payee the opportunity to ask questions of the
officers and management and employees of the Maker and Maker’s Affiliates as well as access to the documents, information
and records of the Maker and Maker’s Affiliates and to acquire additional information about the business and financial condition
of the Maker and Maker’s Affiliates, and Maker confirms that it has made an independent investigation, analysis and evaluation
of the Maker and Maker’s Affiliates and their respective properties, assets, business, financial condition, prospects, documents,
information and records; and

 

8.5
Payee is able to bear the economic risk of holding this Note until the Maturity Date (including total loss of its investment)
and has sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits and
risk of its investment.

 

9.
Costs and Expenses. Maker shall reimburse Payee immediately upon demand the full amount of all payments, advances, charges,
costs and expenses, whether or not collection is instituted hereon, including reasonable attorneys’ fees (to include counsel
fees), expended or incurred by Payee in connection with the enforcement of Payee’s rights and/or the collection of any amounts
which become due to Payee hereunder.

 

10.
Miscellaneous.

 

10.1
Interpretation. The headings and captions in this Note are for convenience of reference only and shall not control or affect
the meaning or construction of any provisions hereof. When used in this Note, the words “including” and “include”
shall be deemed followed by the words “without limitation.”

 

10.2
Waiver. The rights and remedies of Payee under this Note shall be cumulative and not alternative. No waiver by Payee of
any right or remedy under this Note shall be effective unless in a writing signed by Payee. Neither the failure nor any delay
in exercising any right, power or privilege under this Note will operate as a waiver of such right, power or privilege, and no
single or partial exercise of any such right, power or privilege by Payee will preclude any other or further exercise of such
right, power or privilege or the exercise of any other right, power or privilege.

 

    	-5-

     

    

 

10.3
Notices. Any notice required or permitted to be given hereunder shall be given in accordance with Section 8.1 of the Purchase
Agreement.

 

10.4
Governing Law. All questions concerning the construction, validity and interpretation of this Note (whether arising in
tort, contract or otherwise) shall be governed by and construed in accordance with the domestic Laws of the State of Delaware,
without giving effect to any choice of Law or conflict of Law provision (whether of the State of Delaware or any other jurisdiction)
that would cause the application of the Laws of any jurisdiction other than the State of Delaware.

 

10.5
Consent to Jurisdiction. Maker and, by its acceptance of this Note, Payee, each agrees that any action arising out of or
related to this Note shall be conducted only in the State of Delaware. Maker and, by its acceptance of this Note, Payee, each
irrevocably consents and submits to the exclusive personal jurisdiction of and venue in the federal and state courts located in
Wilmington, Delaware. Maker and, by its acceptance of this Note, Payee, each agrees to accept service of any summons, complaint
or other initial pleading made in the manner provided for the giving of notices in Section 8.1 of the Purchase Agreement.

 

10.6
WAIVER OF JURY TRIAL. MAKER AND, BY ITS ACCEPTANCE OF THIS NOTE, PAYEE, EACH IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY
JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM HELD IN ANY COURT ARISING OUT OF OR RELATING TO THIS NOTE.

 

10.7
Severability. The invalidity, illegality or unenforceability of one or more of the clauses or provisions of this Note in
any jurisdiction shall not affect the validity, legality or enforceability of this Note in such jurisdiction or the validity,
legality or enforceability of this Note, including any such clause or provision in any other jurisdiction, it being intended that
all rights and obligations of the parties hereunder shall be enforceable to the fullest extent permitted by Law.

 

10.8
Successors; Assigns; Third-Party Beneficiaries. The provisions of this Note shall be binding upon Maker and Payee and their
respective successors, heirs, beneficiaries, legal representatives and permitted assigns. The rights or obligations of Maker under
this Note may not be assigned by Maker without the prior written consent of Payee. Any attempted assignment in contravention of
this Note shall be null and void and of no effect. This Note is not a negotiable instrument. This Note is for the sole benefit
of the parties hereto and their respective successors, heirs, beneficiaries, legal representatives and permitted assigns and no
provision hereof, whether express or implied, is intended, or shall be construed, to give any other Person any rights or remedies,
whether legal or equitable, hereunder.

 

10.9
Register. Maker may maintain any documentation related to the transfer of this Note, and may maintain a register for the
recordation of the name and address of the applicable Payee(s), and the principal amounts (and stated interest) of this Note owed
to the applicable Payee(s) (the “Register”). The entries in the Register shall be conclusive, absent manifest
error.

 

10.10
Amendments. This Note may not be amended, modified or supplemented except in a writing signed by Maker and Payee.

 

10.11
Construction. All parties and their counsel have reviewed and participated in the preparation of this Note and, accordingly,
the rule of construction that allows a document to be construed more strictly against its author shall not govern the construction
or interpretation of this Note.

 

[Signature
Page Follows]

 

    	-6-

     

    

 

IN
WITNESS WHEREOF, each of Maker and Payee has caused this Note to be duly executed and delivered as of the date first set forth
above.

 

	 	MAKER:
	 	 
	 	Interpace
    BIOPHARMA, Inc.
	 	 	 
	 	By:	/s/
    Jack Stover
	 	Name:	Jack
    Stover
	 	Title:	President
    & Chief Executive Officer

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

[Signature
Page to Subordinated Seller Note]

 

    	 

     

    

 

	 	PAYEE:
	 	 
	 	cancer
    genetics, Inc.
	 	 	 
	 	By:	/s/
    John A. Roberts
	 	Name:	John
    A. Roberts
	 	Its:	President
    & CEO

 

[Remainder
of page intentionally left blank]

 

[Signature
Page to Subordinated Seller Note]EXECUTION
VERSION

 

TRANSITION
SERVICES AGREEMENT

 

This
Transition Services Agreement (this
“Agreement”) is made as of the 15th day of July, 2019 (the “Effective Date”),
by and between Cancer Genetics, Inc., a Delaware corporation (“CGI”) and Interpace BioPharma, Inc.,
a Delaware corporation (“Buyer”). Buyer and CGI are sometimes referred to herein collectively, as the
“Parties” and individually, each a “Party”.

 

Recitals

 

Whereas,
CGI and Buyer are parties to that certain Secured Creditor Asset Purchase Agreement, dated as of July 15, 2019 (as may be amended
from time to time, the “Asset Purchase Agreement”), pursuant to which, among other things, PFG is selling
CGI’s right, title and interest in the Purchased Assets (as such terms are defined in the Asset Purchase Agreement) to Buyer
on the terms and conditions set forth therein;

 

Whereas,
in connection with the Asset Purchase Agreement and following the Closing, Buyer shall provide CGI, or an Affiliate of CGI, certain
services described in Exhibit A attached hereto, for a limited period, subject to the terms and conditions set forth herein;

 

Whereas,
in connection with the Asset Purchase Agreement and following the Closing, CGI shall provide Buyer, or an Affiliate of Buyer,
certain services described in Exhibit B attached hereto, for a limited period, subject to the terms and conditions set
forth herein;

 

Whereas,
in connection with the Asset Purchase Agreement and following the Closing, CGI shall provide Buyer, or an Affiliate of Buyer,
certain payroll and benefit services described in Exhibit C attached hereto, for a limited period, subject to the terms
and conditions set forth herein; and

 

Whereas,
CGI has executed an agreement for the sale of certain assets related to the Clinical Business to a third party, which are not
included in the Purchased Assets and which the foreclosing lender has not foreclosed on (the “Clinical Business Transaction”,
and the third party buyer, the “Clinical Business Buyer”), which sale was consummated on July 8, 2019,
and in connection with the Clinical Business Transaction, following the Closing, Buyer shall provide CGI, or an Affiliate of CGI,
certain services described in Exhibit D attached hereto, as a subcontractor for a limited period, subject to the terms
and conditions set forth herein.

 

Now
Therefore, in consideration of the foregoing
and the representations, warranties and mutual covenants contained herein, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties intending to be legally bound, agree as follows:

 

1.
Definitions. Capitalized terms used and not defined herein shall have the meanings ascribed
to them in the Asset Purchase Agreement.

 

    	 	-1-	 

     

    

 

2.
Transition Services; Payment.

 

(a)
As of the Effective Date, Buyer shall provide and CGI shall accept those transition services that are set forth on Exhibit
A attached hereto and made a part hereof (each, a “Buyer Service” and collectively, the “Buyer
Services”).

 

(b)
As of the Effective Date, CGI shall provide, and Buyer shall accept those transition services that are set forth on Exhibit
B attached hereto and made a part hereof (each, a “CGI Service”, collectively, the “CGI
Services”).

 

(c)
As of the Effective Date, CGI shall provide and Buyer shall accept those payroll and benefit transition services that are
set forth on Exhibit C attached hereto and made a part hereof (each, a “CGI Payroll and Benefit Service”
and collectively, the “CGI Payroll and Benefit Services”).

 

(d)
As of the Effective Date, each Party shall provide, and the other Party shall accept, those transition services that are set
forth on Exhibit D attached hereto and made a part hereof (each, a “Clinical Business Service”
and collectively, the “Clinical Business Services”; the Buyer Services, the CGI Services, the CGI Payroll
and Benefit Services and the Clinical Business Services are collectively referred to herein as the “Services”).
Notwithstanding the foregoing, the Services shall include all activities, tasks and responsibilities that are inherent and reasonably
necessary as part of, or necessary for the proper performance of, the Services.

 

(e)
For avoidance of doubt:

 

(i)
CGI Services shall include (and the Services included on Exhibit B shall in all events include) the specific activities,
tasks, and responsibilities (i) as are reasonably necessary for assistance with the transition of the operation of the BioPharma
Business after the Closing Date and (ii) that have been provided, or reasonably should have been provided, by CGI or any of its
Affiliates to the BioPharma Business on a customary and regular basis during the twelve (12) months preceding the Closing Date.
If, after the Closing Date, the Parties reasonably determine that a service that was reasonably necessary for the operation of
the BioPharma Business after the Closing Date was omitted from Exhibit B, the Parties shall negotiate in good faith
to reach a mutually acceptable agreement with respect to the provision of such service. If the Parties reach a mutual agreement
regarding the provision of such service, then the Parties shall amend Exhibit B to reflect the terms of such mutual agreement,
and the applicable Party shall provide such services to the other Party and such services shall be deemed to be “CGI
Services”;

 

(ii)
the CGI Payroll and Benefit Services means the Services set forth on Exhibit C;

 

(iii)
the Buyer Services shall mean the Services set forth on Exhibit A; and

 

(iv)
the Clinical Business Services shall mean the Services set forth on Exhibit D.

 

(f)
The Parties agree to be bound by any additional conditions, covenants and obligations for a specific Service as set forth
in Exhibit A, Exhibit B, Exhibit C or Exhibit D (such exhibits, collectively, the “Exhibits”)
describing such Service. For the purposes of this Agreement, with respect to any Service, “Receiving Party”
shall mean the Party that is receiving such Service and “Providing Party” shall mean the Party that
is providing such Service.

 

    	 	-2-	 

     

    

 

(g)
Each category of Service shall be provided for the period specified in the applicable Exhibit with respect to such category.
There shall be no fees for the Services other than fees for Services, if any, provided by third parties that a Providing Party
arranges or incurs on behalf of a Receiving Party (“Third Party Services”), which shall be charged at
the direct third-party cost (“Pass Through Costs”); provided, however, the use of any
third party for the provision of any Service hereunder shall be only for Services not provided by the Providing Party itself in
the preceding twelve (12) months and subject to the approval of the Receiving Party, in its reasonable discretion. The Providing
Party will submit monthly invoices to the Receiving Party which shall set forth the amounts due under this Agreement. Each invoice
will specify Pass Through Costs, if any, for each of the Services (by category) provided during the relevant time period. The
Providing Party agrees to afford the Receiving Party, upon reasonable notice, access to such information, records and documentation
of Providing Party as the Receiving Party may reasonably request in order to verify the invoiced amount. The Receiving Party shall
bear its own costs incurred in connection with the verification of the invoiced amounts.

 

(h)
If the Receiving Party in good faith disputes any charges contained in an invoice, the Receiving Party shall promptly submit
to the Providing Party written notice of such dispute and may withhold from the Receiving Party’s payment of the relevant
invoice any such disputed amounts (and only such disputed amounts and excluding any applicable Taxes), up to a maximum of the
amount for the Service(s) to which such dispute relates. The Receiving Party shall remit to the Providing Party the invoiced amount,
minus the amount withheld pursuant to the first sentence of this Section 2(h).

 

(i)
From time to time after the Effective Date, the Parties may mutually agree in writing upon the provision of additional Services
in accordance with the terms of this Agreement (in either case, the “Additional Services”), and shall
negotiate in good faith to reach a mutually acceptable agreement with respect to the provision of such Additional Services. In
the event the Parties agree on such Additional Services, the Exhibits, as applicable, shall be appropriately modified and the
applicable “Services” stated thereon shall be deemed to include such Additional Services.

 

(j)
Notwithstanding anything contained herein to the contrary, any and all Services may be earlier terminated by the Receiving
Party upon fifteen (15) days’ prior written notice to the Providing Party unless terminated earlier with respect to a Third
Party Service upon the termination of the agreements with the third party provider. With respect to a termination of any Service
that occurs other than at an applicable billing cut-off date, the Receiving Party shall pay the prorated fees of certain third
parties as set forth in Section 2(g) above through the date such Services were ceased. The Providing Party agrees and acknowledges
that after a termination of a particular Service (or category of Service) under this Agreement by the Receiving Party (subject
to the payment of the applicable prorated fees by the Receiving Party), the Receiving Party shall no longer have any payment obligations
with respect to such Service (or category of Service, as applicable) unless the Providing Party continues to have an obligation
to pay such fees as approved by the Receiving Party in Section 2(g) above. For the avoidance of doubt, a termination of
a particular Service (or category of Service, as applicable) under this Agreement by a Receiving Party will have no effect on
the Providing Party’s obligation to perform any other Services hereunder.

 

    	 	-3-	 

     

    

 

(k)
Upon the last day on which any services will be provided by CGI under this Agreement, including with respect to the NJ Office
Space Transition Period and the NC Office Space Transition Period, including in the event that the Providing Party becomes insolvent,
files bankruptcy or otherwise becomes unable to perform the Services under this Agreement (the “Transition Services
Expiration Date”), the Providing Party shall deliver to the Receiving Party all records and other information pertaining
to any matters for which the Providing Party was providing Services hereunder; provided, however, that the Providing Party
may retain copies of such records and information to the extent necessary for accounting, tax reporting, compliance with the Providing
Party’s document retention policies or other legitimate business purposes, subject to the requirements of Section 14
and Section 15. The Providing Party acknowledges and agrees that after termination of a particular Service (or category
of Service) under this Agreement by the Receiving Party, the Receiving Party shall not have any payment obligations with respect
to such Service (or category of Service, as applicable) performed after the effective date of such termination and that such termination
by the Receiving Party with respect to any particular Service (or category of Service, as applicable) will not affect the Providing
Party’s obligation to perform any other Service (or category of Service, as applicable) hereunder.

 

(l)
Nothing in this Agreement shall preclude Buyer from obtaining services comparable to the CGI Services or the CGI Payroll and
Benefit Services from its own employees or from providers other than CGI, in whole or in part. Similarly, nothing in this Agreement
shall preclude CGI from obtaining services comparable to the Buyer Services or the Clinical Business Services from its own employees
or from providers other than Buyer, in whole or in part.

 

3.
Term. The term of this Agreement shall commence on the Effective Date and shall continue with
respect to each Service for the longest time period provided in the applicable Exhibit, or such later date as mutually agreed
upon by Buyer and CGI (the “Transition
Period”), unless earlier terminated in accordance with this Agreement.

 

4.
Service Availability; Office Space.

 

(a)
The Parties shall cooperate and use commercially reasonable efforts to obtain the consent of any licensors of software, landlords,
equipment lessors or any other third party that may be required in connection with the provision of any of the Services hereunder
(each, a “Required Consent”). If any such third party requires a payment in order to make any service
available to a Receiving Party, the Providing Party shall notify the Receiving Party of this additional cost and the Parties shall
negotiate in good faith to develop an alternative service that does not require such third party consent. In any such case, subject
to Section 6.18 of the Asset Purchase Agreement, the Receiving Party shall have the option to elect: (i) to pay any amounts
that are required to be paid to any third party to obtain the Required Consent or (ii) to terminate any of the Services associated
with the Required Consent.

 

    	 	-4-	 

     

    

 

(b)
If a Providing Party is or becomes aware that it will be unable to deliver any of the Services, in whole or in part, (whether
or not such inability was foreseeable or within the contemplation of any Party to this Agreement) by reason of fire, flood, storm,
riot, civil commotion, war, act of terrorism or other causes beyond the reasonable control of the Providing Party (each, a “Force
Majeure Event”), the Providing Party shall notify the Receiving Party in writing as soon as practicable of such
inability and cooperate with the Receiving Party to arrange for replacement services reasonably acceptable to the Receiving Party
during the period in which the Force Majeure Event is ongoing. The party suffering a Force Majeure Event shall resume the performance
of its obligations under this Agreement as soon as reasonably practicable after the removal of the cause of the Force Majeure
Event.

 

(c)
During the NJ Office Space Transition Period (as defined below), CGI shall provide the office space, including all existing
telecom and other office equipment, for the reasonable use of Buyer employees and its Affiliates and Representatives on the premises
leased under the NJ Lease. The “NJ Office Space Transition Period” shall mean the period beginning on
the Closing Date and continuing until the date on which the NJ Lease has been validly assigned (with the landlord’s consent)
to, and assumed by Buyer. Buyer shall bear all costs and expenses associated with and under the NJ Lease, including, but not limited
to, rent, during the NJ Office Space Transition Period.

 

(d)
During the NC Office Space Transition Period (as defined below), CGI shall provide the office space, including all existing
telecom and other office equipment, for the reasonable use of Buyer employees and its Affiliates and Representatives on the premises
leased under the NC Lease. The “NC Office Space Transition Period” shall mean the period beginning on
the Closing Date and continuing until the date on which the NC Lease has been validly assigned (with the landlord’s consent)
to, and assumed by Buyer. Buyer shall bear all costs and expenses associated with and under the NC Lease, including, but not limited
to, rent, during the NC Office Space Transition Period.

 

(e)
During the Office Space Transition Period (as defined below), Buyer shall provide office space, including existing telecom
and other office equipment, for the reasonable use of CGI employees, Affiliates and Representatives on the premises leased under
the NC Lease and the NJ Lease, as applicable, as reasonably required for the performance of the applicable Services and the Ongoing
CGI Tasks. The “Office Space Transition Period” shall mean the period beginning on the Closing Date
and continuing until the later of (a) December 31, 2019 and (b) Transition Services Expiration Date. There shall be no cost to
or expense borne by CGI, or any of its Affiliates or Representatives, for the use and occupancy of and access to such office space
during the Office Space Transition Period. CGI’s employees and its Affiliates and Representatives shall not interfere with
Buyer’s use of the NJ Lease and NC Lease premises and shall abide by all terms of the NJ Lease and the NC Lease in connection
with its use of office space during the Office Space Transition Period.

 

(f)
It is acknowledged by Buyer that, subject to the terms and provisions of this Agreement and the Asset Purchase Agreement,
during the Services Period, CGI employees, including the BP Employees, may continue to perform for CGI, from time to time, tasks
(the “Ongoing CGI Tasks”) previously performed in the ordinary course of business in the last twelve
(12) months for CGI related to (i) legal, accounting, accounts receivable and accounts payable matters and (ii) the FHACT and
TOO tests (“Retained Clinical Tests”); provided, however, that the performance of such tasks
shall not unreasonably interfere with Buyer’s operations and the provision of services to Buyer under this Agreement, and
CGI shall reimburse and indemnify Buyer for all costs and expenses associated with the Ongoing CGI Tasks.

 

    	 	-5-	 

     

    

 

5.
Representations and Warranties regarding Services.

 

(a)
Each of Buyer and CGI represents, warrants and agrees that the Services to be provided by each such Party shall be provided
in compliance with CLIA, CAP, applicable state clinical laboratory and cGMP regulations in a professional and workmanlike manner,
in accordance with applicable Law and in the same manner in all material respects that such services were provided with regard
to the BioPharma Business, the Clinical Business, the Discovery Business and general corporate matters, as applicable, in the
twelve (12) months prior to the Closing Date, including with respect to the dedication of resources and the quality and timeliness
of such services, but in no event with less than reasonable skill and care.

 

(b)
EXCEPT AS EXPRESSLY PROVIDED IN SECTION 5(a) AND SECTION 6, THE SERVICES TO BE PROVIDED UNDER THIS AGREEMENT
ARE FURNISHED WITHOUT ANY REPRESENTATIONS AND WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, WITH RESPECT TO THE SERVICES, INCLUDING,
WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WHICH ARE SPECIFICALLY DISCLAIMED. EXCEPT
AS EXPRESSLY PROVIDED IN SECTION 5(a) AND SECTION 6, THE PARTIES MAKE NO REPRESENTATIONS OR WARRANTIES AS TO THE
QUALITY, SUITABILITY OR ADEQUACY OF THE SERVICES FOR ANY PURPOSE OR USE.

 

6.
Representations, Warranties and Covenants of CGI

 

(a)
Representations and Warranties. CGI hereby represents and warrants to Buyer that (i) the execution and delivery by CGI of,
and the consummation by CGI of the transactions contemplated by, this Agreement, and compliance with the terms hereof by CGI,
do not and shall not: (A) (w) conflict with or result in a breach of the terms, conditions or provisions of, (x) constitute a
default under, (y) give any third party the right to modify, terminate or accelerate any obligation under or (z) result in a violation
of the charter or organizational documents of CGI, any Law or order to which CGI is subject or any contract (whether written or
oral) to which CGI is party or subject; or (B) require any authorization, consent, approval, license, permit, exemption or other
action by or notice or declaration to, or filing with, any Governmental Authority pursuant to the charter or organizational documents
of CGI, any Law or order to which CGI is subject or any contract (whether written or oral) to which CGI is subject, (ii) it has
all requisite corporate power and authority, and has taken all corporate action necessary, to execute and deliver this Agreement,
to consummate the transactions contemplated hereby and to perform its obligations hereunder, (iii) this Agreement has been duly
executed and delivered by CGI and, assuming that this Agreement is valid and binding on Buyer, constitutes a legal, valid and
binding obligation of CGI, enforceable against CGI in accordance with its terms and (iv) it has provided to Buyer a true and complete
copy of the sale agreement (including schedules and exhibits thereto) relating to the Clinical Business Transaction, which is
in full force and effect.

 

    	 	-6-	 

     

    

 

(b)
Compliance with Laws. CGI shall perform the CGI Services and the CGI Payroll and Benefit Services pursuant to this Agreement
in a manner that complies with all applicable Laws and orders or other actions or requirements of any Governmental Authority that
are applicable to CGI’s performance pursuant to this Agreement or to the CGI Services or the CGI Payroll and Benefit Services.

 

(c)
Resources and Ability. CGI is and shall remain able to provide the CGI Services and the CGI Payroll and Benefit Services during
the Transition Period for such Service. CGI has and shall have and maintain for the duration of the Transition Period for such
Service sufficient resources and personnel to perform its obligations pursuant to this Agreement.

 

(d)
Additional Representation and Covenant of CGI Related to the Clinical Business Services. CGI hereby represents and warrants
that it has transferred to Buyer pursuant to the Asset Purchase Agreement all of the Intellectual Property and/or related rights
that are necessary or useful for Buyer to perform the Clinical Business Services for and during the applicable periods set forth
in Exhibit D. If, following the Closing, Buyer reasonably determines that any Intellectual Property and/or related rights that
are necessary or useful for Buyer to perform the Clinical Business Services for and during the applicable periods set forth in
Exhibit D have not been so transferred to Buyer pursuant to the Asset Purchase Agreement, then CGI shall immediately transfer
or license (on a non-exclusive, royalty-free basis) to Buyer such Intellectual Property and/or related rights solely so that Buyer
may perform the Clinical Business Services for and during the applicable periods set forth in Exhibit D.

 

7.
Representations and Warranties of Buyer.

 

(a)
Representations and Warranties. Buyer hereby represents and warrants to CGI that (i) the execution and delivery by Buyer of,
and the consummation by Buyer of the transactions contemplated by, this Agreement, and compliance with the terms hereof by Buyer,
do not and shall not: (A) (w) conflict with or result in a breach of the terms, conditions or provisions of, (x) constitute a
default under, (y) give any third party the right to modify, terminate or accelerate any obligation under or (z) result in a violation
of the charter or organizational documents of Buyer, any Law or order to which Buyer is subject or any contract (whether written
or oral) to which Buyer is party or subject; or (B) require any authorization, consent, approval, exemption or other action by
or notice or declaration to, or filing with, any Governmental Authority pursuant to the charter or organizational documents of
Buyer, any Law or order to which Buyer is subject or any contract (whether written or oral) to which Buyer is subject, (ii) it
has all requisite corporate power and authority, and has taken all corporate action necessary, to execute and deliver this Agreement,
to consummate the transactions contemplated hereby and to perform its obligations hereunder, and (iii) this Agreement has been
duly executed and delivered by Buyer and, assuming that this Agreement is valid and binding on CGI, constitutes a legal, valid
and binding obligation of Buyer, enforceable against Buyer in accordance with its terms.

 

(b)
Compliance with Laws. Buyer shall perform the Buyer Services and the Clinical Business Services pursuant to this Agreement
in a manner that complies with all applicable Laws and orders or other actions or requirements of any Governmental Authority that
are applicable to Buyer’s performance pursuant to this Agreement or to the Buyer Services or the Clinical Business Services.

 

    	 	-7-	 

     

    

 

(c)
Resources and Ability. Assuming CGI’s continued compliance with Section 6(c) and the other post-closing covenants
under the Asset Purchase Agreement, Buyer is and shall remain able to provide the Buyer Services during the Transition Period
for such Service. Assuming CGI’s continued compliance with Section 6(c) and the other post-closing covenants under
the Asset Purchase Agreement, Buyer has and shall have and maintain for the duration of the Transition Period for such Service
sufficient resources and personnel to perform its obligations with respect to such Service pursuant to this Agreement.

 

8.
Representatives. CGI and Buyer shall each designate, from time to time, a representative to
act as CGI’s and Buyer’s respective primary contact persons to coordinate the provision of all of the Services (collectively,
the “Primary Coordinators”). Each Primary Coordinator may designate
one or more service coordinators for each specific Service (collectively, the “Service Coordinators”).
The names and contact information of the Primary Coordinators and Services Coordinators shall be listed on Exhibit E hereto.
Each Party may treat an act of a Primary Coordinator of another Party as being authorized by such other Party without inquiring
behind such act or ascertaining whether such Primary Coordinator had authority to so act, and each Party may treat an act of a
Service Coordinator as being authorized by such other Party only to the extent such act is directly related to the Service for
which such Service Coordinator has been designated; provided, however, that no such Primary Coordinator or Service Coordinator
has authority to amend this Agreement, except as set forth in a duly authorized written amendment in accordance with Section
18. CGI and Buyer shall advise each other promptly (and in any event within seven days) in writing of any change in the
Primary Coordinators and any Service Coordinator for a particular Service. CGI and Buyer agree that all communications relating
to the provision of the Services shall be directed to the Service Coordinators for such Service, with concurrently sent copies
to the Primary Coordinators.

 

9.
Cooperation. During the term of the longest Transition Period, the Parties shall use commercially
reasonable efforts to cooperate with each other in all matters relating to the provision and receipt of the Services. Such reasonable
cooperation shall include exchanging information, providing electronic access to systems used in connection with the Services,
performing true-ups and adjustments and using commercially reasonable efforts (including payment of any commercially reasonable
fees or expenses) to obtain all consents, licenses, sublicenses or approvals necessary to permit each Party to perform its obligations
hereunder, in each case subject to the restrictions of Section 14. The Parties shall use commercially reasonable efforts
to cooperate with each other in determining the extent to which any Tax is due and owing with respect to the Services and in providing
and making available any resale certificate, information regarding out-of-state use of materials, services or sale and other exemption
certificates or information reasonably requested by either Party. In addition, during such Transition Period, each Providing Party
shall offer such reasonable assistance to the Receiving Party to transfer responsibility for the provision of each applicable
Services to the Receiving Party or a new provider.

 

    	 	-8-	 

     

    

 

10.
Audit Rights. During the term of the longest Transition Period and for a one-year period thereafter,
the Receiving Party shall have the right, on reasonable notice and during business hours, to inspect and audit the books, accounts
and records of the Providing Party pertaining to the applicable Service for the purpose of verifying the amounts invoiced to the
Receiving Party hereunder. If the Receiving Party wishes to perform an audit with respect to any fees or Service, then the Receiving
Party will cooperate in such audit, including by making available documents, information and personnel to the employees and/or
accounting firm appointed by the Receiving Party for the purposes of such audit. The Receiving Party shall bear the costs and
expenses of any inspection and audit unless the inspection reveals that the Providing Party overbilled Buyer by 5% or more with
respect to any period being audited, in which case the Providing Party shall bear 100% of the costs and expenses of such inspection
and audit.

 

11.
Indemnification.

 

(a)
Indemnification by CGI.

 

(i)
CGI shall indemnify and hold Buyer and its Affiliates harmless against any damages, costs and expenses (including reasonable attorneys’
fees and expenses) arising from (A) any gross negligence, fraud or intentional misconduct by or on behalf of CGI or its Affiliates
in connection with the provision of any CGI Service or CGI Payroll and Benefit Service or the receipt or use of any Buyer Service
or Clinical Business Service or any other actions or inactions by or on behalf of CGI or its Affiliates in connection therewith,
(B) any alleged joint employer status with respect to Buyer and its Affiliates, on the one hand, and CGI and its Affiliates, on
the other hand, or (C) any breach by or on behalf of CGI or its Affiliates of any of its obligations hereunder.

 

(ii)
If notified promptly in writing of any action brought against Buyer or its Affiliates based on a claim described in Section
11(a)(i) above, CGI and its Affiliates shall defend such action at their expense and pay all costs, damages and settlements
finally awarded in such action or settlement which are attributable to such claim. CGI shall have sole control of the defense
of any such action and all negotiations for its settlement or compromise, provided, that, such settlement or compromise
(A) includes an unconditional release of Buyer and its Affiliates from all liability with respect to such claim, (B) does not
include any award for specific performance, injunctive relief or other equitable remedy and (C) is in form and substance reasonably
satisfactory to Buyer. Buyer shall reasonably cooperate with CGI, at CGI’s expense, in the defense of such claim, and may
be represented, at Buyer’s expense, by counsel of Buyer’s selection.

 

(iii)
Subject to the other provisions of this Agreement, indemnification claims arising under this Agreement, including control of proceedings
and limitations, shall be governed by the applicable provisions of Article 7 of the Asset Purchase Agreement; it being acknowledged
and agreed by the Parties that any indemnification of the Buyer Indemnified Parties under this Agreement shall be effected as
set forth in Section 7.5(d) of the Asset Purchase Agreement.

 

(iv)
Notwithstanding anything to the contrary in this Agreement, if CGI is in breach of this Agreement, Buyer may continue to enjoy
the benefits of this Agreement, including remaining in possession of the premises under the NJ Lease, without prejudice to any
rights, remedies and claims of Buyer arising from CGI’s breach.

 

    	 	-9-	 

     

    

 

(b)
Indemnification by Buyer.

 

(i)
Buyer shall indemnify and hold CGI and its Affiliates harmless against any damages, costs and expenses (including reasonable attorneys’
fees and expenses) arising from (A) any gross negligence, fraud or intentional misconduct by or on behalf of Buyer or its Affiliates
in connection with the provision of any Buyer Service or Clinical Business Service or the receipt or use of any CGI Service or
CGI Payroll and Benefit Service or any other actions or inactions by or on behalf of Buyer in connection therewith or (B) any
breach by or on behalf of Buyer or its Affiliates of any of its obligations hereunder.

 

(ii)
If notified promptly in writing of any action brought against CGI or its Affiliates based on a claim described in Section 11(b)(i)
above, Buyer shall defend such action at its expense and pay all costs, damages and settlements finally awarded in such action
or settlement which are attributable to such claim. Buyer shall have sole control of the defense of any such action and all negotiations
for its settlement or compromise, provided, that, such settlement or compromise (A) includes an unconditional release of
CGI and its Affiliates from all liability with respect to such claim, (B) does not include any award for specific performance,
injunctive relief or other equitable remedy and (C) is in form and substance reasonably satisfactory to CGI. CGI shall reasonably
cooperate with Buyer, at Buyer’s expense, in the defense of such claim, and may be represented, at CGI’s expense,
by counsel of CGI’s selection.

 

12.
Remedies. Because of the special nature of the Services and the disruption to the Receiving
Party that could ensue from the Providing Party’s failure in breach of this Agreement to provide any of the Services, the
Parties agree that the Receiving Party would be irreparably harmed by any such failure. For these reasons, the Providing Party
agrees that the Receiving Party shall be entitled to injunctive relief, including the Providing Party’s specific performance
of its obligations under this Agreement without requirement of posting a bond, in addition to all other remedies available to
the Receiving Party in law or at equity or otherwise for any such breach. Except as set forth herein, all rights, powers and remedies
herein given to each Party are cumulative and not alternative and are in addition to all statutes or rules of Law. Any forbearance
or delay by such Party in exercising the same shall not be deemed to be a waiver thereof, the exercise of any right or partial
exercise thereof shall not preclude the further exercise thereof and the same shall continue in full force and effect until specifically
waived by an instrument in writing executed by such Party.

 

13.
Limitation of Liability. EXCEPT IN THE CASE OF FRAUD, IN NO EVENT SHALL EITHER PARTY BE LIABLE
FOR ANY EXEMPLARY OR PUNITIVE DAMAGES RELATING TO THE SALE, DELIVERY, PROVISION OR USE OF THE SERVICES OR ANY BREACH OF THIS AGREEMENT.

 

    	 	-10-	 

     

    

 

14.
Confidentiality.

 

(a)
In the process of providing and receiving the Services or otherwise in connection with this Agreement, a Party may have access
to Confidential Information (as hereinafter defined) of another Party. Without limiting the applicability of any other obligation
of confidentiality to which the Parties or their Affiliates may be bound, each Party agrees to keep (and to cause its Affiliates
and its and their respective employees, agents and independent contractors to keep) any Confidential Information of the other
Party strictly in confidence, not to disclose it to any third party without prior written approval of the other Party and to use
it only for the purposes set forth in this Agreement, except (i) as required by applicable Law, in which case the relevant Party
shall notify the other Party prior to disclosing such Confidential Information and shall use its commercially reasonable efforts
to obtain a protective order or otherwise prevent or minimize disclosure of such Confidential Information, or (ii) with the express
prior written approval of the other Party.

 

(b)
In the event that either Party or anyone to whom either Party disclosed any Confidential Information shall be legally compelled
or required by any Government Authority to disclose any Confidential Information of the other Party, such compelled Party agrees
to promptly provide written notice to such other Party to enable such other Party, at such other Party’s cost and expense,
to seek a protective order or other appropriate remedy to avoid public or third-party disclosure of such Confidential Information.
In the event that such protective order or other remedy is not obtained, such compelled Party shall furnish only so much of such
Confidential Information as it is legally compelled to disclose (upon advice of such compelled Party’s legal counsel) and
shall exercise such compelled Party’s commercially reasonable efforts to obtain reliable assurance that confidential treatment
will be accorded such Confidential Information.

 

(c)
For purposes of this Agreement, “Confidential Information” means any confidential information of
Buyer or CGI, including, without limitation, with respect to methods of operation, customers, customer lists, products, prices,
fees, costs, technology, inventions, trade secrets, know-how, software, marketing methods, plans, personnel, suppliers, competitors,
markets or other specialized information or proprietary matters, and any Data provided by one Party to the other in accordance
with Section 15. The obligation of confidentiality set forth in Section 14(a) above shall not extend to: (i) information
that at the time of disclosure was in the public domain or thereafter comes into the public domain without breach of this Agreement
by the receiving Party and (ii) information that becomes known to the receiving Party from a source, other than the disclosing
Party, that had a valid right to possess such information and without breach of this Agreement by the receiving Party.

 

(d)
In connection with the provision and performance of the Services, the Providing Party shall at all times: (A) comply in all
material respects with its own then in-force security guidelines and policies applicable thereto; (B) treat any Confidential Information
generated, collected or stored for the Receiving Party or its Affiliates with a standard of care at least equal to the standard
of care afforded the Providing Party’s own Confidential Information, and in no event at a standard less than reasonable
care; and (C) comply with all applicable Laws related to the protection and storage of and access to any such Confidential Information.

 

(e)
Where the Providing Party receives access to the computer systems of the Receiving Party or its Affiliates, it shall comply
in all material respects with such Party’s security guidelines and policies.

 

    	 	-11-	 

     

    

 

(f)
In the event that the Providing Party becomes aware that unauthorized access or use of Receiving Party’s or its Affiliates’
Confidential Information has occurred, it shall: (A) promptly (and in any event within two Business Days) notify the Receiving
Party (and/or its respective Affiliates) of such unauthorized access or use; (B) inform Receiving Party (and/or its Affiliates),
and promptly keep Receiving Party (and/or its Affiliates) fully informed of all details related to such unauthorized access or
use; and (C) cooperate with the Receiving Party (and/or its Affiliates) in good faith to remedy any ongoing unauthorized access
or use.

 

(g)
Upon the expiration or earlier termination of any Service, but except to the extent otherwise required by applicable Law,
each Party shall, and shall cause its respective Affiliates to, return all Confidential Information of the other Party received
under or pursuant to the provision or receipt of such Service.

 

15.
Ownership and Maintenance of Data. All records, data files (and the data contained therein),
input materials, reports and other materials provided by a Providing Party by or at the direction of the Providing Party pursuant
to this Agreement (collectively, “Data”)
will be and remain the exclusive property of the Providing Party. Neither the Receiving Party nor any of its Affiliates will possess
any interest, title, lien or right with respect thereto or in connection therewith. The Receiving Party will not, and will cause
its Affiliates not to, use the Data for any purpose other than in support of its obligations hereunder. Neither the Data nor any
part thereof will be disclosed, sold, assigned, leased or otherwise disposed of to third parties by the Receiving Party or any
of its Affiliates, or commercially exploited by or on behalf of the Receiving Party or any of its Affiliates or their respective
employees or agents, other than in accordance with the terms of this Agreement or the Asset Purchase Agreement. If the Receiving
Party (a) determines on the advice of its counsel that it is required to disclose any of the Data pursuant to applicable Law or
(b) receives any demand under lawful process to disclose or provide any of the Data to any other person or party, including a
Governmental Authority, then the terms of Section 14(b) shall apply to and control the disclosure of any such Data by the
Receiving Party. Upon termination of any Service provided hereunder, each Party will provide the other Party reasonable access
to any Data associated with the provision of such Service for a period not to exceed one (1) year following the termination of
such Service, whereupon any such Data remaining with the Receiving Party will be transferred to Providing Party or otherwise made
available to the Providing Party as the Providing Party may reasonably request.

 

16.
Expiration. Upon the earlier of the expiration or termination of all CGI Services and CGI Payroll
and Benefit Services under this Agreement, except as otherwise provided in the Asset Purchase Agreement or any other Ancillary
Agreement:

 

(a)
CGI and its Affiliates will no longer make any use of any of the Purchased Assets or rights in respect of the BioPharma Business.

 

(b)
Notwithstanding anything to the contrary contained herein, any account receivable relating to the BioPharma Business collected
by CGI or its Affiliates under this Agreement shall be for the account of Buyer.

 

17.
Independent Contractor. With respect to each Service, the Providing Party shall be deemed to
be an independent contractor of the Receiving Party, and not an employee, agent, partner, joint employer or joint venture partner
of the Receiving Party in the performance of its obligations hereunder. The Providing Party shall be solely responsible for compensation
and benefits to its personnel assigned to perform the Services hereunder, including, but not limited to, worker’s compensation,
disability benefits, unemployment insurance and withholding, employment or any other taxes imposed or assessed on such employees.

 

    	 	-12-	 

     

    

 

18.
Entire Agreement; Amendment. This Agreement, the Asset Purchase Agreement, and the schedules
and exhibits hereto and thereto, collectively, contain the entire agreement and understanding between the Parties with respect
to the subject matter hereof and supersede all prior and contemporaneous agreements, negotiations, correspondence, undertakings
and understandings, oral or written, relating to such subject matter. No amendment to or modification of this Agreement shall
be effective unless it shall be in writing and signed by each of Buyer and CGI.

 

19.
Severability. If any provision of this Agreement is held by final judgment of a court of competent
jurisdiction to be invalid, illegal or unenforceable, such invalid, illegal or unenforceable provision shall be severed from the
remainder of this Agreement and the remainder of this Agreement shall be enforced. In addition, the invalid, illegal or unenforceable
provision shall be deemed to be automatically modified, and, as so modified, to be included in this Agreement, such modification
being made to the minimum extent necessary to render the provision valid, legal and enforceable. Notwithstanding the foregoing,
if the severed or modified provision concerns all or a portion of the essential consideration to be delivered under this Agreement
by one Party to the other, the remaining provisions of this Agreement shall also be modified to the extent necessary to adjust
equitably the Parties’ respective rights and obligations hereunder.

 

20.
Construction. The headings of the sections and paragraphs of this Agreement have been inserted
for convenience of reference only and shall in no way restrict or otherwise modify any of the terms or provisions hereof. In the
negotiation of this Agreement, each Party has received advice from its own attorney. The language used in this Agreement is the
language chosen by the Parties to express their mutual intent, and no provision of this Agreement will be interpreted for or against
any Party because that Party or its attorney drafted the provision.

 

21.
Resolution of Disputes; Continuation of Services Pending Outcome of Dispute. In the event of
any dispute between the Parties, the Parties agree to resolve such dispute in accordance with Sections 8.9, 8.11 and 8.12 of the
Asset Purchase Agreement. Notwithstanding any dispute between the Parties, neither CGI, on the one hand, or Buyer, on the other
hand, shall discontinue the supply of any Service pending the resolution of such dispute.

 

22.
No Modification of Asset Purchase Agreement. The Parties hereby expressly agree that this Agreement
does not, and shall not be construed to, alter or amend in any way the rights and obligations of the Parties pursuant to the Asset
Purchase Agreement, and any rights and obligations thereunder shall have priority over the rights and obligations of the Parties
hereunder.

 

23.
Waiver. Waiver of any term or condition of this Agreement by any Party shall be effective if
in writing and shall not be construed as a waiver of any subsequent breach or failure of the same term or condition, or a waiver
of any other term of this Agreement. No failure or delay by any Party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or
the exercise of any other right, power or privilege.

 

    	 	-13-	 

     

    

 

24.
Governing Law. This Agreement, including any disputes hereunder (whether arising in contract,
tort or at law) or the interpretation hereof, shall be governed by and construed in accordance with the internal laws of the State
of Delaware applicable to agreements made and to be performed entirely within the State of Delaware, without regard to the conflicts
of law principles thereof or any other jurisdiction.

 

25.
Notices. All notices, requests, demands, claims and other communications that are required to
be or may be given under this Agreement shall be delivered in accordance with, and effective as set forth in, Section 8.1 of the
Asset Purchase Agreement.

 

26.
Assignment. Any of the Parties may (a) assign this Agreement to any Affiliate of such Party
or direct or indirect subsidiary of a parent of such Party so long as any such assignee agrees in writing to be bound by all of
the provisions of this Agreement and such Party continues to remain secondarily liable for all obligations hereunder, and (b)
assign its rights under this Agreement to any Person that acquires a majority of the equity interests of such Party or substantially
all of the assets of such Party. Each Party may assign to its Affiliates its right to receive a payment entitled to be received
by it pursuant to this Agreement without any prior written consent. No Party shall otherwise assign this Agreement or any part
hereof without the prior written consent of the other Party. Subject to the foregoing, this Agreement shall be binding upon and
inure to the benefit of the Parties and their respective permitted successors and assigns.

 

27.
Parties in Interest. Nothing in this Agreement is intended to provide any rights or remedies
to any Person other than the Parties.

 

28.
Survival. Sections 1, 5 through 28 and any other sections of this Agreement that expressly so
provide, shall survive and continue in full force and effect following any termination or expiration of this Agreement.

 

29.
Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed
an original and both of which, when taken together, shall constitute one agreement. Any signature page delivered by a facsimile
machine or electronic mail shall be binding to the same extent as an original signature page with regard to any agreement subject
to the terms hereof or any amendment thereto.

 

[Signature
Page Follows.]

 

    	 	-14-	 

     

    

 

In
Witness Whereof, each party hereto has executed
or caused this Agreement to be executed in its name by a duly authorized officer as of the day and year first above written.

 

[Signature
Page to Transition Services Agreement]

 

    	 	 	 

     

    

 

	 	CANCER
    GENETICS, INC.
	 	 	 
	 	By:	/s/
    John A. Roberts
	 	Name:	John
    A. Roberts
	 	Title:	President
    & CEO

 

[Remainder
of page intentionally left blank]

 

[Signature
Page to Transition Services Agreement]

 

    	 	 	 

     

    

 

	 	INTERPACE
    BIOPHARMA, INC.
	 	 	 
	 	By:	/s/
    Jack Stover
	 	Name:	Jack
    Stover
	 	Title:	President
    & Chief Executive Officer

 

[Signature
Page to Transition Services Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]